Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Curr Opin Pulm Med

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    November 2017
  1. CARPAIJ OA, van den Berge M
    The asthma-obesity relationship: underlying mechanisms and treatment implications.
    Curr Opin Pulm Med. 2017 Nov 23. doi: 10.1097/MCP.0000000000000446.
    PubMed     Text format     Abstract available


    October 2017
  2. KOCKS JWH, Seys SF, van Duin TS, Diamant Z, et al
    Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000447.
    PubMed     Text format     Abstract available


  3. AL-SAJEE D, Oliveria JP, Sehmi R, Gauvreau GM, et al
    Antialarmins for treatment of asthma: future perspectives.
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000443.
    PubMed     Text format     Abstract available


  4. NYENHUIS SM, Apter AJ, Schatz M, Krishnan JA, et al
    Comparative effectiveness trials in asthma - how will I recognize one?
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000442.
    PubMed     Text format     Abstract available


  5. BOULET LP
    Airway remodeling in asthma: update on mechanisms and therapeutic approaches.
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000441.
    PubMed     Text format     Abstract available


  6. PITE H, Morais-Almeida M, Rocha SM
    Metabolomics in asthma: where do we stand?
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000437.
    PubMed     Text format     Abstract available


  7. HUMBERT M, Busse W, Hanania NA
    Controversies and opportunities in severe asthma.
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000438.
    PubMed     Text format     Abstract available


  8. HANANIA NA, Diamant Z
    The road to precision medicine in asthma: challenges and opportunities.
    Curr Opin Pulm Med. 2017 Oct 17. doi: 10.1097/MCP.0000000000000444.
    PubMed     Text format    


  9. BONINI M, Usmani OS
    Novel methods for device and adherence monitoring in asthma.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000439.
    PubMed     Text format     Abstract available


  10. PARULEKAR AD, Kao CC, Diamant Z, Hanania NA, et al
    Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000436.
    PubMed     Text format     Abstract available


  11. CHUNG KF
    Precision medicine in asthma: linking phenotypes to targeted treatments.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000434.
    PubMed     Text format     Abstract available


  12. BRAIDO F, Baiardini I, Canonica GW
    Patient-reported outcomes in asthma clinical trials.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000440.
    PubMed     Text format     Abstract available


    July 2017

  13. Improving adherence to asthma medications: current knowledge and future perspectives: Erratum.
    Curr Opin Pulm Med. 2017;23:376.
    PubMed     Text format    


    March 2017
  14. OBERLE AJ, Mathur P
    Precision medicine in asthma: the role of bronchial thermoplasty.
    Curr Opin Pulm Med. 2017 Mar 17. doi: 10.1097/MCP.0000000000000372.
    PubMed     Text format     Abstract available


  15. ALTER A, Aboussouan LS, Mireles-Cabodevila E
    Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.
    Curr Opin Pulm Med. 2017;23:129-138.
    PubMed     Text format     Abstract available


  16. KWO E, Christiani D
    The role of gene-environment interplay in occupational and environmental diseases: current concepts and knowledge gaps.
    Curr Opin Pulm Med. 2017;23:173-176.
    PubMed     Text format     Abstract available


  17. HARRINGTON SE, Rogers E, Davis M
    Palliative care and chronic obstructive pulmonary disease: where the lines meet.
    Curr Opin Pulm Med. 2017;23:154-160.
    PubMed     Text format     Abstract available


  18. TSAI SC
    Chronic obstructive pulmonary disease and sleep related disorders.
    Curr Opin Pulm Med. 2017;23:124-128.
    PubMed     Text format     Abstract available


  19. RAGHAVAN D, Varkey A, Bartter T
    Chronic obstructive pulmonary disease: the impact of gender.
    Curr Opin Pulm Med. 2017;23:117-123.
    PubMed     Text format     Abstract available


  20. HANSON C, LeVan T
    Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions.
    Curr Opin Pulm Med. 2017;23:149-153.
    PubMed     Text format     Abstract available


  21. SEHGAL IS, Dhooria S, Agarwal R
    Chronic obstructive pulmonary disease and malnutrition in developing countries.
    Curr Opin Pulm Med. 2017;23:139-148.
    PubMed     Text format     Abstract available


    February 2017
  22. ABO-LEYAH H, Chalmers JD
    New therapies for the prevention and treatment of exacerbations of bronchiectasis.
    Curr Opin Pulm Med. 2017 Feb 16. doi: 10.1097/MCP.0000000000000368.
    PubMed     Text format     Abstract available


    January 2017
  23. DIAMANT Z, Hanania NA
    Generic medications in precision medicine in asthma.
    Curr Opin Pulm Med. 2017;23:1-2.
    PubMed     Text format    


    November 2016
  24. TRIVEDI V, Apala DR, Iyer VN
    Occupational asthma: diagnostic challenges and management dilemmas.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  25. PARULEKAR AD, Diamant Z, Hanania NA
    Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  26. SEYS SF
    Role of sputum biomarkers in the management of asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  27. BOULET LP, Turmel J, Cote A
    Asthma and exercise-induced respiratory symptoms in the athlete: new insights.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  28. D'AMATO M, Vitale C, Molino A, Lanza M, et al
    Anticholinergic drugs in asthma therapy.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  29. BAKIRTAS A
    Diagnostic challenges of childhood asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  30. MUKHERJEE M, Svenningsen S, Nair P
    Glucocortiosteroid subsensitivity and asthma severity.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  31. SATTLER C, Garcia G, Humbert M
    Novel targets of omalizumab in asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  32. SAMITAS K, Zervas E, Gaga M
    T2-low asthma: current approach to diagnosis and therapy.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  33. ASH SY, Diaz AA
    The role of imaging in the assessment of severe asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  34. KERSTEN ET, Koppelman GH
    Pharmacogenetics of asthma: toward precision medicine.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  35. BONINI M
    Electronic health (e-Health): emerging role in asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  36. SINGANAYAGAM A, Ritchie AI, Johnston SL
    Role of microbiome in the pathophysiology and disease course of asthma.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


  37. BLAKE KV
    Improving adherence to asthma medications: current knowledge and future perspectives.
    Curr Opin Pulm Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  38. DY R, Sethi S
    The lung microbiome and exacerbations of COPD.
    Curr Opin Pulm Med. 2016;22:196-202.
    PubMed     Text format     Abstract available


    March 2016
  39. PATEL HJ
    An update on pharmacologic management of chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2016;22:119-24.
    PubMed     Text format     Abstract available


  40. BROWN JP, Martinez CH
    Chronic obstructive pulmonary disease comorbidities.
    Curr Opin Pulm Med. 2016;22:113-8.
    PubMed     Text format     Abstract available


  41. JONES GL
    Quality of life changes over time in patients with chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2016;22:125-9.
    PubMed     Text format     Abstract available


  42. RAGHAVAN D, Bartter T, Joshi M
    How to reduce hospital readmissions in chronic obstructive pulmonary disease?
    Curr Opin Pulm Med. 2016;22:106-12.
    PubMed     Text format     Abstract available


  43. RUSSELL DW, Wells JM, Blalock JE
    Disease phenotyping in chronic obstructive pulmonary disease: the neutrophilic endotype.
    Curr Opin Pulm Med. 2016;22:91-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: